Research programme: acne vaccine - UC San Diego/sanofi pasteur

Drug Profile

Research programme: acne vaccine - UC San Diego/sanofi pasteur

Alternative Names: Acne vaccine - sanofi pasteur; Acne vaccine - University of California in San Diego/sanofi pasteur

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of California, San Diego
  • Developer Sanofi Pasteur; University of California, San Diego
  • Class Vaccines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Acne

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Acne in USA
  • 21 Sep 2011 University of California, San Diego's acne vaccine licensed to sanofi pasteur worldwide for the treatment/prevention of Acne
  • 21 Sep 2011 Preclinical trials in Acne in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top